Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Dr Reddys Laboratories (RDY) Shares Outstanding (Weighted Average) (2017 - 2026)

Dr Reddys Laboratories has reported Shares Outstanding (Weighted Average) over the past 10 years, most recently at $9.1 million for Q1 2026.

  • For Q1 2026, Shares Outstanding (Weighted Average) fell 5.16% year-over-year to $9.1 million; the TTM value through Mar 2026 reached $9.1 million, down 5.16%, while the annual FY2026 figure was $9.1 million, 8.66% down from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 was $9.1 million at Dr Reddys Laboratories, down from $9.6 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $11.1 million in Q1 2022 and troughed at $9.1 million in Q1 2026.
  • A 5-year average of $10.0 million and a median of $10.0 million in 2024 define the central range for Shares Outstanding (Weighted Average).
  • Biggest five-year swings in Shares Outstanding (Weighted Average): soared 386.47% in 2022 and later decreased 8.73% in 2023.
  • Year by year, Shares Outstanding (Weighted Average) stood at $11.1 million in 2022, then fell by 8.73% to $10.1 million in 2023, then decreased by 0.56% to $10.0 million in 2024, then decreased by 4.1% to $9.6 million in 2025, then fell by 5.16% to $9.1 million in 2026.
  • Business Quant data shows Shares Outstanding (Weighted Average) for RDY at $9.1 million in Q1 2026, $9.6 million in Q1 2025, and $10.0 million in Q1 2024.